(Q39436145)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22124136%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Histone deacetylase inhibitors impair NK cell viability and effector functions through inhibition of activation and receptor expression (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22124136%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22124136%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Raúl German Spallanzani

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22124136%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Carolina I Domaica

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22124136%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Norberto Zwirner

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22124136%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Lucas E Rossi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22124136%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Damián E Avila

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22124136%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Andrea Ziblat

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22124136%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Lara Lapyckyj

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22124136%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Diego O Croci

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22124136%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Gabriel A Rabinovich

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22124136%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

28 November 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22124136%20AND%20SRC:MED&resulttype=core&format=json

Journal of Leukocyte Biology

17 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22124136%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

91

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22124136%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22124136%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

321-331

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22124136%20AND%20SRC:MED&resulttype=core&format=json

Histone acetyltransferases

17 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0711339

Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0711339

HDAC6 expression is correlated with better survival in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0711339

Anticancer activities of histone deacetylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0711339

Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0711339

Drug Insight: histone deacetylase inhibitor-based therapies for cutaneous T-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0711339

Histone deacetylase inhibitors in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0711339

Surface NK receptors and their ligands on tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0711339

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0711339

Cytokine regulation of natural killer cell effector functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0711339

Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0711339

HDAC3 represses the expression of NKG2D ligands ULBPs in epithelial tumour cells: potential implications for the immunosurveillance of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0711339

Histone deacetylase inhibitors sensitize tumour cells for cytotoxic effects of natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0711339

Cancer cells become susceptible to natural killer cell killing after exposure to histone deacetylase inhibitors due to glycogen synthase kinase-3-dependent expression of MHC class I-related chain A and B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0711339

Effective in vivo induction of NKG2D ligands in acute myeloid leukaemias by all-trans-retinoic acid or sodium valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0711339

Histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0711339

Deacetylase inhibition promotes the generation and function of regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0711339

Differential effects of selective HDAC inhibitors on macrophage inflammatory responses to the Toll-like receptor 4 agonist LPS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0711339

Histone deacetylase activities are required for innate immune cell control of Th1 but not Th2 effector cell function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0711339

Intracellular retention of the NKG2D ligand MHC class I chain-related gene A in human melanomas confers immune privilege and prevents NK cell-mediated cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0711339

Engagement of TLR3, TLR7, and NKG2D regulate IFN-gamma secretion but not NKG2D-mediated cytotoxicity by human NK cells stimulated with suboptimal doses of IL-12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0711339

Histone deacetylase inhibitors: a new perspective for the treatment of leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0711339

Role of thioredoxin in the response of normal and transformed cells to histone deacetylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0711339

Antiepileptic drugs in non-epilepsy disorders: relations between mechanisms of action and clinical efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0711339

Cancer risk in long-term users of valproate: a population-based case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0711339

Acute leukemia associated with valproic acid treatment: a novel mechanism for leukemogenesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0711339

Translocation-positive acute myeloid leukemia associated with valproic acid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0711339

Polycystic ovarian syndrome in women with epilepsy: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0711339

NKG2D ligand expression in AML increases in response to HDAC inhibitor valproic acid and contributes to allorecognition by NK-cell lines with single KIR-HLA class I specificities

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0711339

Regulation of the expression of MHC class I-related chain A, B (MICA, MICB) via chromatin remodeling and its impact on the susceptibility of leukemic cells to the cytotoxicity of NKG2D-expressing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0711339

Autocrine role of endogenous interleukin-18 on inflammatory cytokine generation by human neutrophils.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0711339

HDAC inhibition prevents NF-kappa B activation by suppressing proteasome activity: down-regulation of proteasome subunit expression stabilizes I kappa B alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0711339

Histone deacetylase inhibitors suppress the inducibility of nuclear factor-kappaB by tumor necrosis factor-alpha receptor-1 down-regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0711339

Butyrate suppression of colonocyte NF-kappa B activation and cellular proteasome activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0711339

Up on the tightrope: natural killer cell activation and inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0711339

Functions of natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0711339

Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0711339

Histone deacetylase inhibitors suppress natural killer cell cytolytic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0711339

Histone deacetylase inhibitors prevent activation of tumour-reactive NK cells and T cells but do not interfere with their cytolytic effector functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0711339

Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0711339

Tumor immunoediting by NKp46.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0711339

NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0711339

Enhanced in vivo growth of lymphoma tumors in the absence of the NK-activating receptor NKp46/NCR1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0711339

NKG2D function protects the host from tumor initiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0711339